anti human cd45 pe Search Results


94
Guangzhou JET Bio-Filtration pe anti-human cd45 antibody
Pe Anti Human Cd45 Antibody, supplied by Guangzhou JET Bio-Filtration, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+human+cd45+pe/PE+Anti-Human+CD45+Antibody/custom%40e-ab-f1137d%4037789395
Average 94 stars, based on 1 article reviews
pe anti-human cd45 antibody - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

93
Cytek Biosciences cd45 pe cy7
Cd45 Pe Cy7, supplied by Cytek Biosciences, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+human+cd45+pe/PE-Cyanine7+Anti-Human+CD45/pmc05094194-139-12-10
Average 93 stars, based on 1 article reviews
cd45 pe cy7 - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

93
Proteintech cd45 phycoerythrin
Cd45 Phycoerythrin, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+human+cd45+pe/PE+Anti-human+CD45/pmc11140314-120-14-19
Average 93 stars, based on 1 article reviews
cd45 phycoerythrin - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

93
Elabscience Biotechnology cd45
Fig. 1 The identification of MSCs and the exosomes isolated from MSCs. A and B Flow cytometry analysis was performed to analyze the expression of hematopoietic markers of MSCs (CD11b, <t>CD45</t> and CD34) and their marker proteins (CD105, CD90, and CD73). C The morphology of MSCs and their abili ties to differentiate into adipocytes and osteoblasts were observed or analyzed using a microscope, oil red O staining experiment, and ALP assay. D-F The identification of the isolated exosomes from MSCs by TEM, NTA analysis and western blotting assay
Cd45, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+human+cd45+pe/PE+Anti-Human+CD45+Antibody/pm40537786-78-14-16
Average 93 stars, based on 1 article reviews
cd45 - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

92
Diaclone anti cd45 pe
Fig. 1 The identification of MSCs and the exosomes isolated from MSCs. A and B Flow cytometry analysis was performed to analyze the expression of hematopoietic markers of MSCs (CD11b, <t>CD45</t> and CD34) and their marker proteins (CD105, CD90, and CD73). C The morphology of MSCs and their abili ties to differentiate into adipocytes and osteoblasts were observed or analyzed using a microscope, oil red O staining experiment, and ALP assay. D-F The identification of the isolated exosomes from MSCs by TEM, NTA analysis and western blotting assay
Anti Cd45 Pe, supplied by Diaclone, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+human+cd45+pe/Anti-Human+CD45+Monoclonal+Antibody%2C+PE+Conjugated+Clone+B-A11/pmc06565890-66-9-12
Average 92 stars, based on 1 article reviews
anti cd45 pe - by Bioz Stars, 2026-08
92/100 stars
  Buy from Supplier

89
Cytek Biosciences human cd45
Figure 1. ENTPD1 expression is increased within human cSCC and correlated with metastasis. (a) Measurement of ENTPD1 expression in unmatched human NS and cSCC by qPCR for ENTPD1 mRNA (n ¼ 8 for NS, n ¼ 10 for cSCC) and (b) detection of ENTPD1þ cells by flow cytometry of fresh tissue (n ¼ 11 for NS, n ¼ 13 for cSCC). (c) Analysis of human primary SCC for ENTPD1 expression among peritumoral immune cells by IHC in tumors that metastasized ([þ] Met, n ¼ 54) versus those that did not ([‒] Met, n ¼ 51). (d) ENTPD1 expression within CD45þ and CD45e populations of cells by flow cytometry of fresh tissue (n ¼ 11 for NS, n ¼ 13 for cSCC). (e) In vivo expression of ENTPD1 within the stroma of cSCC. Dotted lines indicate the epidermal‒dermal junction. Bar ¼ 200 mm. (f) ENTPD1 expression by CD3þ T cells (n ¼ 13) isolated from human cSCC, peritumoral NL skin, and blood. Each data point represents one patient sample. P- values were determined by unpaired t-test. cSCC, cutaneous squamous cell carcinoma; ENTPD1, ectonucleotidase triphosphate diphosphodydrolase 1; IHC, immunohistochemistry; Met, metastasized; NL, nonlesional; NS, normal skin; SCC, squamous cell carcinoma.
Human Cd45, supplied by Cytek Biosciences, used in various techniques. Bioz Stars score: 89/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+human+cd45+pe/PE+Anti-Human+CD45/pm33848530-178-2-25
Average 89 stars, based on 1 article reviews
human cd45 - by Bioz Stars, 2026-08
89/100 stars
  Buy from Supplier

90
Litron Laboratories LTD anti-human-cd45-pe hi30
Figure 1. ENTPD1 expression is increased within human cSCC and correlated with metastasis. (a) Measurement of ENTPD1 expression in unmatched human NS and cSCC by qPCR for ENTPD1 mRNA (n ¼ 8 for NS, n ¼ 10 for cSCC) and (b) detection of ENTPD1þ cells by flow cytometry of fresh tissue (n ¼ 11 for NS, n ¼ 13 for cSCC). (c) Analysis of human primary SCC for ENTPD1 expression among peritumoral immune cells by IHC in tumors that metastasized ([þ] Met, n ¼ 54) versus those that did not ([‒] Met, n ¼ 51). (d) ENTPD1 expression within CD45þ and CD45e populations of cells by flow cytometry of fresh tissue (n ¼ 11 for NS, n ¼ 13 for cSCC). (e) In vivo expression of ENTPD1 within the stroma of cSCC. Dotted lines indicate the epidermal‒dermal junction. Bar ¼ 200 mm. (f) ENTPD1 expression by CD3þ T cells (n ¼ 13) isolated from human cSCC, peritumoral NL skin, and blood. Each data point represents one patient sample. P- values were determined by unpaired t-test. cSCC, cutaneous squamous cell carcinoma; ENTPD1, ectonucleotidase triphosphate diphosphodydrolase 1; IHC, immunohistochemistry; Met, metastasized; NL, nonlesional; NS, normal skin; SCC, squamous cell carcinoma.
Anti Human Cd45 Pe Hi30, supplied by Litron Laboratories LTD, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+human+cd45+pe/anti+human+cd45+pe+hi30/pmc08597720-76-26-39
Average 90 stars, based on 1 article reviews
anti-human-cd45-pe hi30 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

93
Elabscience Biotechnology pe cy7 anti cd45
Figure 1. ENTPD1 expression is increased within human cSCC and correlated with metastasis. (a) Measurement of ENTPD1 expression in unmatched human NS and cSCC by qPCR for ENTPD1 mRNA (n ¼ 8 for NS, n ¼ 10 for cSCC) and (b) detection of ENTPD1þ cells by flow cytometry of fresh tissue (n ¼ 11 for NS, n ¼ 13 for cSCC). (c) Analysis of human primary SCC for ENTPD1 expression among peritumoral immune cells by IHC in tumors that metastasized ([þ] Met, n ¼ 54) versus those that did not ([‒] Met, n ¼ 51). (d) ENTPD1 expression within CD45þ and CD45e populations of cells by flow cytometry of fresh tissue (n ¼ 11 for NS, n ¼ 13 for cSCC). (e) In vivo expression of ENTPD1 within the stroma of cSCC. Dotted lines indicate the epidermal‒dermal junction. Bar ¼ 200 mm. (f) ENTPD1 expression by CD3þ T cells (n ¼ 13) isolated from human cSCC, peritumoral NL skin, and blood. Each data point represents one patient sample. P- values were determined by unpaired t-test. cSCC, cutaneous squamous cell carcinoma; ENTPD1, ectonucleotidase triphosphate diphosphodydrolase 1; IHC, immunohistochemistry; Met, metastasized; NL, nonlesional; NS, normal skin; SCC, squamous cell carcinoma.
Pe Cy7 Anti Cd45, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+human+cd45+pe/PE%2FCyanine7+Anti-Human+CD45+Antibody/pm39805186-50-14-21
Average 93 stars, based on 1 article reviews
pe cy7 anti cd45 - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

94
Biogems International cd45
Figure 1. ENTPD1 expression is increased within human cSCC and correlated with metastasis. (a) Measurement of ENTPD1 expression in unmatched human NS and cSCC by qPCR for ENTPD1 mRNA (n ¼ 8 for NS, n ¼ 10 for cSCC) and (b) detection of ENTPD1þ cells by flow cytometry of fresh tissue (n ¼ 11 for NS, n ¼ 13 for cSCC). (c) Analysis of human primary SCC for ENTPD1 expression among peritumoral immune cells by IHC in tumors that metastasized ([þ] Met, n ¼ 54) versus those that did not ([‒] Met, n ¼ 51). (d) ENTPD1 expression within CD45þ and CD45e populations of cells by flow cytometry of fresh tissue (n ¼ 11 for NS, n ¼ 13 for cSCC). (e) In vivo expression of ENTPD1 within the stroma of cSCC. Dotted lines indicate the epidermal‒dermal junction. Bar ¼ 200 mm. (f) ENTPD1 expression by CD3þ T cells (n ¼ 13) isolated from human cSCC, peritumoral NL skin, and blood. Each data point represents one patient sample. P- values were determined by unpaired t-test. cSCC, cutaneous squamous cell carcinoma; ENTPD1, ectonucleotidase triphosphate diphosphodydrolase 1; IHC, immunohistochemistry; Met, metastasized; NL, nonlesional; NS, normal skin; SCC, squamous cell carcinoma.
Cd45, supplied by Biogems International, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+human+cd45+pe/Anti-Human+CD45+PE/pm37186211-263-13-17
Average 94 stars, based on 1 article reviews
cd45 - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

92
Biogems International anti cd45pe cyanine7
Figure 1. ENTPD1 expression is increased within human cSCC and correlated with metastasis. (a) Measurement of ENTPD1 expression in unmatched human NS and cSCC by qPCR for ENTPD1 mRNA (n ¼ 8 for NS, n ¼ 10 for cSCC) and (b) detection of ENTPD1þ cells by flow cytometry of fresh tissue (n ¼ 11 for NS, n ¼ 13 for cSCC). (c) Analysis of human primary SCC for ENTPD1 expression among peritumoral immune cells by IHC in tumors that metastasized ([þ] Met, n ¼ 54) versus those that did not ([‒] Met, n ¼ 51). (d) ENTPD1 expression within CD45þ and CD45e populations of cells by flow cytometry of fresh tissue (n ¼ 11 for NS, n ¼ 13 for cSCC). (e) In vivo expression of ENTPD1 within the stroma of cSCC. Dotted lines indicate the epidermal‒dermal junction. Bar ¼ 200 mm. (f) ENTPD1 expression by CD3þ T cells (n ¼ 13) isolated from human cSCC, peritumoral NL skin, and blood. Each data point represents one patient sample. P- values were determined by unpaired t-test. cSCC, cutaneous squamous cell carcinoma; ENTPD1, ectonucleotidase triphosphate diphosphodydrolase 1; IHC, immunohistochemistry; Met, metastasized; NL, nonlesional; NS, normal skin; SCC, squamous cell carcinoma.
Anti Cd45pe Cyanine7, supplied by Biogems International, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+human+cd45+pe/Anti-Human+CD45+PE-Cyanine7/pm39182566-46-29-31
Average 92 stars, based on 1 article reviews
anti cd45pe cyanine7 - by Bioz Stars, 2026-08
92/100 stars
  Buy from Supplier


Image Search Results


Fig. 1 The identification of MSCs and the exosomes isolated from MSCs. A and B Flow cytometry analysis was performed to analyze the expression of hematopoietic markers of MSCs (CD11b, CD45 and CD34) and their marker proteins (CD105, CD90, and CD73). C The morphology of MSCs and their abili ties to differentiate into adipocytes and osteoblasts were observed or analyzed using a microscope, oil red O staining experiment, and ALP assay. D-F The identification of the isolated exosomes from MSCs by TEM, NTA analysis and western blotting assay

Journal: Journal of inflammation (London, England)

Article Title: Mesenchymal stem cell-derived exosomal CBLB ameliorates infantile pneumonia progression probably by ubiquitinating MAPK14.

doi: 10.1186/s12950-025-00450-0

Figure Lengend Snippet: Fig. 1 The identification of MSCs and the exosomes isolated from MSCs. A and B Flow cytometry analysis was performed to analyze the expression of hematopoietic markers of MSCs (CD11b, CD45 and CD34) and their marker proteins (CD105, CD90, and CD73). C The morphology of MSCs and their abili ties to differentiate into adipocytes and osteoblasts were observed or analyzed using a microscope, oil red O staining experiment, and ALP assay. D-F The identification of the isolated exosomes from MSCs by TEM, NTA analysis and western blotting assay

Article Snippet: The cells were incubated with PE-conjugated fluorescent antibodies against CD11b (E-AB-F1081D, Elabscience, Wuhan, China), CD45 (E-AB-F1137D, Elabscience), CD34 (E-ABF1143D, Elabscience), CD105 (E-AB-F1310D, Elabscience), CD90 (E-AB-F1167D, Elabscience), and CD73 (E-AB-F1242D, Elabscience).

Techniques: Isolation, Flow Cytometry, Expressing, Marker, Microscopy, Staining, ALP Assay, Western Blot

Figure 1. ENTPD1 expression is increased within human cSCC and correlated with metastasis. (a) Measurement of ENTPD1 expression in unmatched human NS and cSCC by qPCR for ENTPD1 mRNA (n ¼ 8 for NS, n ¼ 10 for cSCC) and (b) detection of ENTPD1þ cells by flow cytometry of fresh tissue (n ¼ 11 for NS, n ¼ 13 for cSCC). (c) Analysis of human primary SCC for ENTPD1 expression among peritumoral immune cells by IHC in tumors that metastasized ([þ] Met, n ¼ 54) versus those that did not ([‒] Met, n ¼ 51). (d) ENTPD1 expression within CD45þ and CD45e populations of cells by flow cytometry of fresh tissue (n ¼ 11 for NS, n ¼ 13 for cSCC). (e) In vivo expression of ENTPD1 within the stroma of cSCC. Dotted lines indicate the epidermal‒dermal junction. Bar ¼ 200 mm. (f) ENTPD1 expression by CD3þ T cells (n ¼ 13) isolated from human cSCC, peritumoral NL skin, and blood. Each data point represents one patient sample. P- values were determined by unpaired t-test. cSCC, cutaneous squamous cell carcinoma; ENTPD1, ectonucleotidase triphosphate diphosphodydrolase 1; IHC, immunohistochemistry; Met, metastasized; NL, nonlesional; NS, normal skin; SCC, squamous cell carcinoma.

Journal: The Journal of investigative dermatology

Article Title: ENTPD1 (CD39) Expression Inhibits UVR-Induced DNA Damage Repair through Purinergic Signaling and Is Associated with Metastasis in Human Cutaneous Squamous Cell Carcinoma.

doi: 10.1016/j.jid.2021.02.753

Figure Lengend Snippet: Figure 1. ENTPD1 expression is increased within human cSCC and correlated with metastasis. (a) Measurement of ENTPD1 expression in unmatched human NS and cSCC by qPCR for ENTPD1 mRNA (n ¼ 8 for NS, n ¼ 10 for cSCC) and (b) detection of ENTPD1þ cells by flow cytometry of fresh tissue (n ¼ 11 for NS, n ¼ 13 for cSCC). (c) Analysis of human primary SCC for ENTPD1 expression among peritumoral immune cells by IHC in tumors that metastasized ([þ] Met, n ¼ 54) versus those that did not ([‒] Met, n ¼ 51). (d) ENTPD1 expression within CD45þ and CD45e populations of cells by flow cytometry of fresh tissue (n ¼ 11 for NS, n ¼ 13 for cSCC). (e) In vivo expression of ENTPD1 within the stroma of cSCC. Dotted lines indicate the epidermal‒dermal junction. Bar ¼ 200 mm. (f) ENTPD1 expression by CD3þ T cells (n ¼ 13) isolated from human cSCC, peritumoral NL skin, and blood. Each data point represents one patient sample. P- values were determined by unpaired t-test. cSCC, cutaneous squamous cell carcinoma; ENTPD1, ectonucleotidase triphosphate diphosphodydrolase 1; IHC, immunohistochemistry; Met, metastasized; NL, nonlesional; NS, normal skin; SCC, squamous cell carcinoma.

Article Snippet: Antibodies to human CD45, CD3, CD4, CD8, CD45R0, CLA, ENTPD1, CD73, CD11b, CD11c, CD206, DC-SIGN, PD-L1, PD-L2, PD-1, gdTCR, FoxP3, and IL17A were purchased from Tonbo Biotechnologies, eBioscience, Bio- Legend, R&D Systems (Minneapolis, MN), and BD Biosciences.

Techniques: Expressing, Cytometry, In Vivo, Isolation, Immunohistochemistry